21 – 30 of 362
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer
2024) In BJUI Compass(
- Contribution to journal › Article
-
Mark
Population-based Organised Prostate Cancer Testing : Results from the First Invitation of 50-year-old Men
(
- Contribution to journal › Article
-
Mark
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research
2024) In Nature Reviews Urology(
- Contribution to journal › Article
-
Mark
Baseline characteristics and clinical outcomes of prostate cancer patients on delayed palliative management : a PIONEER analysis based on big data
(
- Contribution to journal › Article
-
Mark
Evaluating Biparametric Versus Multiparametric Magnetic Resonance Imaging for Diagnosing Clinically Significant Prostate Cancer : An International, Paired, Noninferiority, Confirmatory Observer Study
2024) In European Urology(
- Contribution to journal › Article
-
Mark
AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by the OPTIMA Consortium
(
- Contribution to journal › Scientific review
-
Mark
A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing
(
- Contribution to journal › Article
-
Mark
Targeted Investigational Treatment Analysis of Novel Anti-androgen (TITAN) study : ultralow prostate-specific antigen decline with apalutamide plus androgen-deprivation therapy
(
- Contribution to journal › Article
- 2023
-
Mark
Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer
(
- Contribution to journal › Article